{
    "clinical_study": {
        "@rank": "28533", 
        "acronym": "REFLECT", 
        "arm_group": [
            {
                "arm_group_label": "Fentanyl", 
                "arm_group_type": "Active Comparator", 
                "description": "fentanyl bolus injections on an \"as needed\" base, next to the fentanyl bolus injections on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium."
            }, 
            {
                "arm_group_label": "Remifentanil", 
                "arm_group_type": "Active Comparator", 
                "description": "remifentanil, starting with 0.15 ug/Ideal Body Weight(IBW)(kg)/min, next to fentanyl bolus injections (200-500 ug) on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will investigate the influence of intra-operative use of remifentanil versus\n      fentanyl on the percentage of patients with chronic thoracic after cardiac surgery via\n      sternotomy. Secondary quantitative sensory testing is performed to determine thermal and\n      electrical detection and pain threshold and the difference in pain variability scoring.\n      Postoperative pain scores, analgesic use, genetic variances and costs are measured."
        }, 
        "brief_title": "Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain", 
        "condition": [
            "Chronic Pain", 
            "Sternotomy", 
            "Remifentanil", 
            "Fentanyl"
        ], 
        "condition_browse": {
            "mesh_term": "Chest Pain"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing cardiac surgery via sternotomy (Coronary artery bypass graft\n             (CABG) and/or valve replacement)\n\n          -  Patients admitted to the ICU or PACU in the St. Antonius hospital\n\n          -  Patients between 18 and 85 years old\n\n          -  Patients weighing between 45 and 140 kg\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Pregnancy/ breastfeeding\n\n          -  Language barrier\n\n          -  History of drug abuse\n\n          -  Neurologic condition such as peripheral neuropathy\n\n          -  Known remifentanil, fentanyl, morphine or paracetamol allergy\n\n          -  Body Mass Index (BMI) > 35 kg/m2"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "126", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031016", 
            "org_study_id": "REFLECT study"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fentanyl", 
                "description": "fentanyl bolus injections on an \"as needed\" base, NEXT TO the fentanyl bolus injections on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.", 
                "intervention_name": "Fentanyl", 
                "intervention_type": "Drug", 
                "other_name": "Sublimaze"
            }, 
            {
                "arm_group_label": "Remifentanil", 
                "description": "starting with 0.15 ug/IBW(kg)/min, next to fentanyl bolus injections (200-500 ug) on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "Ultiva"
            }, 
            {
                "arm_group_label": [
                    "Fentanyl", 
                    "Remifentanil"
                ], 
                "description": "fentanyl bolus injections on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.", 
                "intervention_name": "Fentanyl", 
                "intervention_type": "Drug", 
                "other_name": "Sublimaze"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fentanyl", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic thoracic pain", 
            "Remifentanil", 
            "Fentanyl", 
            "sternotomy"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "s.de.hoogd@antoniusziekenhuis.nl", 
                "last_name": "S. de Hoogd, MSc.", 
                "phone": "+3130-6093500"
            }, 
            "facility": {
                "address": {
                    "city": "Nieuwegein", 
                    "country": "Netherlands"
                }, 
                "name": "St. Antonius Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised Clinical Trial Evaluating the Effect of Remifentanil vs Fentanyl During Cardiac Surgery on the Incidence of Chronic Thoracic Pain", 
        "overall_contact": {
            "email": "s.de.hoogd@antoniusziekenhuis.nl", 
            "last_name": "S. de Hoogd, MSc", 
            "phone": "+3130-6093500"
        }, 
        "overall_official": {
            "affiliation": "St. Antonius Hospital", 
            "last_name": "CAJ Knibbe, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)"
            ]
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The percentage of patients reporting chronic thoracic pain one year after cardiac surgery.", 
            "measure": "Chronic thoracic pain", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031016"
        }, 
        "responsible_party": {
            "investigator_affiliation": "St. Antonius Hospital", 
            "investigator_full_name": "Catherijne Knibbe", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The percentage of patients reporting chronic thoracic pain three months and six months after cardiac surgery", 
                "measure": "Chronic thoracic pain", 
                "safety_issue": "No", 
                "time_frame": "3 and 6 months"
            }, 
            {
                "description": "The mean NRS score of patients with chronic thoracic pain three months and six months after cardiac surgery.", 
                "measure": "Mean Numerical Rating Scale (NRS) score", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months"
            }, 
            {
                "description": "The quality of life (QoL) three months, six months and one year after surgery.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months"
            }, 
            {
                "description": "The difference in postoperative pain thresholds three days and one year after cardiac surgery compared to the preoperative pain threshold (baseline)", 
                "measure": "Thermal detection and pain thresholds", 
                "safety_issue": "No", 
                "time_frame": "preoperative, 3 days postoperative and 1 year after surgery"
            }, 
            {
                "description": "Pain variability measured with a paradigm with electrical stimuli in only a part of the participants. The difference in pain variability preoperative, three days postoperative and one year after cardiac surgery.", 
                "measure": "Pain variability", 
                "safety_issue": "No", 
                "time_frame": "preoperative, 3 days and 1 year postoperative"
            }, 
            {
                "description": "The required amounts of analgesics (morphine/paracetamol) during hospital stay; The use of analgesics three months, six months and one year after cardiac surgery, measured with questionnaires;", 
                "measure": "Use of analgesics during and after hospitalization", 
                "safety_issue": "No", 
                "time_frame": "3 days during hospitalization and 3,6,12 months post surgery"
            }, 
            {
                "description": "Genetic variances involved in pain sensitivity (e.g. GTP-cyclohydrolase 1 (GCH-1), WDFY4, Zinc Finger gene Family (ZNF), Melanocortin 1 Receptor (MC1R)) and pharmacokinetics and pharmacodynamics of opiates (e.g. glucuronosyl transferase (UGT), Multidrug Resistance-associated Protein (MRP), mu-opioid receptor gene 1 (OPRM1), Catechol-O-methyltransferase (COMT))", 
                "measure": "Genetic variances", 
                "safety_issue": "No", 
                "time_frame": "Blood sample at time of surgery"
            }, 
            {
                "measure": "Total medical costs and productivity costs during one year, including costs of hospitalization days (ICU and non-ICU) and costs of medications", 
                "safety_issue": "No", 
                "time_frame": "1 year after surgery"
            }, 
            {
                "description": "Mean NRS score during intensive care unit (ICU) stay and hospitalization.", 
                "measure": "Mean pain NRS (Numerical Rating Scale)", 
                "safety_issue": "No", 
                "time_frame": "3-5 days during hospitalization"
            }
        ], 
        "source": "St. Antonius Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Antonius Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}